G6PD-Mediated iron dysregulation and ferroptosis in BAG3-associated myofibrillar myopathy: a study initiated from a single rare Chinese case

BAG3 p.Pro209Leu causes severe childhood-onset myofibrillar myopathy (Bag3opathy). However, due to the extreme rarity of this disease, systematic molecular profiling in human patients remains largely unexplored to date. Here, we leveraged serum proteomics and metabolomics in the first reported Chinese patient with BAG3 p.Pro209Leu versus 30 age-matched healthy controls to identify disease-specific molecular signatures, followed by functional validation in CRISPR-generated Bag3 P215L knock-in mice and CRISPR-edited C2C12 myoblasts. At 3 months of age, Bag3 P215L knock-in mice exhibited significant muscle weakness and motor dysfunction. Patient serum showed marked reductions in antioxidant enzymes (SOD1, catalase) and pronounced glucose-6-phosphate accumulation with near-absent G6PD activity. In Bag3 P215L mice and mutant cells, G6PD activity and NADPH were reduced, labile iron and lipid peroxidation increased, mitochondria displayed ferroptosis-like ultrastructural changes, and cells were more susceptible to ferroptotic triggers. G6PD deficiency correlated with lower expression of iron chaperones PCBP1/2 and increased transferrin. Pharmacological activation or genetic restoration of G6PD partially rescued PCBP1/2 levels, normalized transferrin, reduced lipid peroxidation and improved cell survival. Collectively, our findings define a patient-driven pathogenic axis linking BAG3 mutation, G6PD deficiency, iron dysregulation, and ferroptosis, and highlight G6PD activation as a promising therapeutic strategy for this rare disease. Further studies in larger patient cohorts and longitudinal animal models are warranted.

Authors

Institutions

Publication Details

Journal
Cell Biology and Toxicology
Published
2026-11-13
DOI
https://doi.org/10.1007/s10565-026-10323-8
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

G6PD-Mediated iron dysregulation and ferroptosis in BAG3-associated myofibrillar myopathy: a study initiated from a single rare Chinese case

Yan Chen, 童铁军, Wenwen Si, Zhaoxiang Bian et al.
3 links
Cell Biology and Toxicology
Muscle Physiology and Disorders
article

G6PD-Mediated iron dysregulation and ferroptosis in BAG3-associated myofibrillar myopathy: a study initiated from a single rare Chinese case

Yan Chen, 童铁军, Wenwen Si, Zhaoxiang Bian, Tao Huang, Gengyu Bao, Dongfeng Chen, Ling Zhao, Chengyuan Lin, Guangzhi Zeng, Aijun Liu, Min Zhuang, Linda Zhong, Shuxian Wang, Yi Li
article en

Abstract

BAG3 p.Pro209Leu causes severe childhood-onset myofibrillar myopathy (Bag3opathy). However, due to the extreme rarity of this disease, systematic molecular profiling in human patients remains largely unexplored to date. Here, we leveraged serum proteomics and metabolomics in the first reported Chinese patient with BAG3 p.Pro209Leu versus 30 age-matched healthy controls to identify disease-specific molecular signatures, followed by functional validation in CRISPR-generated Bag3 P215L knock-in mice and CRISPR-edited C2C12 myoblasts. At 3 months of age, Bag3 P215L knock-in mice exhibited significant muscle weakness and motor dysfunction. Patient serum showed marked reductions in antioxidant enzymes (SOD1, catalase) and pronounced glucose-6-phosphate accumulation with near-absent G6PD activity. In Bag3 P215L mice and mutant cells, G6PD activity and NADPH were reduced, labile iron and lipid peroxidation increased, mitochondria displayed ferroptosis-like ultrastructural changes, and cells were more susceptible to ferroptotic triggers. G6PD deficiency correlated with lower expression of iron chaperones PCBP1/2 and increased transferrin. Pharmacological activation or genetic restoration of G6PD partially rescued PCBP1/2 levels, normalized transferrin, reduced lipid peroxidation and improved cell survival. Collectively, our findings define a patient-driven pathogenic axis linking BAG3 mutation, G6PD deficiency, iron dysregulation, and ferroptosis, and highlight G6PD activation as a promising therapeutic strategy for this rare disease. Further studies in larger patient cohorts and longitudinal animal models are warranted.

Cell Biology and Toxicology
Ningbo University (CN), Guangzhou University of Chinese Medicine (CN), Hong Kong Baptist University (HK), Nanyang Technological University (SG), Anhui University of Traditional Chinese Medicine (CN)
Good health and well-being
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon